Biologic and advanced immunomodulating therapeutic options for sarcoidosis: a clinical update

TNF inhibitor treating osseous sarcoidosis and dactylitis: case and literature review

(2020) Diala Alawneh et al.   CLINICAL RHEUMATOLOGY

Sarcoidosis and the mTOR, Rac1, and Autophagy Triad

(2020) Yves Pacheco et al.   TRENDS IN IMMUNOLOGY

Interleukin‐1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST‐Segment–Elevation Myocardial Infarction

(2020) Antonio Abbate et al.   Journal of the American Heart Association

Comprehensive Care for Patients with Sarcoidosis

(2020) Catharina C. Moor et al.   Journal of Clinical Medicine

Bone Marrow-Derived Mesenchymal Stromal Cells (MSCs) Modulate the Inflammatory Character of Alveolar Macrophages from Sarcoidosis Patients

(2020) Ian McClain Caldwell et al.   Journal of Clinical Medicine

Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline

(2020) Elliott D. Crouser et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease

(2020) Antonio Abbate et al.   CIRCULATION RESEARCH

Scar sarcoidosis following rituximab therapy

(2020) Nicole C. Vesely et al.   Dermatologic Therapy

Tocilizumab‐induced sarcoidosis‐like reaction in a patient with giant cell arteritis. Clinical implications of a paradoxical phenomenon

(2020) Grigorios Theodosiou et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

ACUTE EFFECTS OF INTERLEUKIN-1 BLOCKADE USING ANAKINRA IN PATIENTS WITH ACUTE PERICARDITIS

(2020) George F. Wohlford et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Refractory Sarcoidosis: A Review

(2020) Thomas El Jammal et al.   Therapeutics and Clinical Risk Management

Management of repository corticotrophin injection therapy for pulmonary sarcoidosis: a Delphi study

(2020) Franck F. Rahaghi et al.   European Respiratory Review

Clinical phenotyping: role in treatment decisions in sarcoidosis

(2020) Robert P. Baughman et al.   European Respiratory Review

Successful Response to Treatment with Sirolimus in Pulmonary Sarcoidosis

(2020) Nishant Gupta et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Health-Related Quality of Life in Sarcoidosis

(2020) Ogugua Ndili Obi   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Infliximab treatment in pathology-confirmed neurosarcoidosis

(2020) Daan Fritz et al.   Neurology-Neuroimmunology & Neuroinflammation

Are Patients at Risk for Recurrent Disease Activity After Switching From Remicade® to Remsima®? An Observational Study

(2020) Laixi Xue et al.   Frontiers in Medicine

Phagosome-regulated mTOR Signalling during Sarcoidosis Granuloma Biogenesis

(2020) Elliott D. Crouser et al.   EUROPEAN RESPIRATORY JOURNAL

Systemic Sarcoidosis Associated with Certolizumab Pegol Treatment for Rheumatoid Arthritis: A Case Report and Review of the Literature

(2020) Keigo Koda et al.   INTERNAL MEDICINE

The Tale of IL-12 and IL-23: A Paradigm Shift

(2019) Shabaana A. Khader et al.   JOURNAL OF IMMUNOLOGY

Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study

(2019) Alice Bitossi et al.   MEDIATORS OF INFLAMMATION

Infliximab biosimilar for treating neurosarcoidosis: tolerance and efficacy in a retrospective study including switch from the originator and initiation of treatment

(2019) Quentin Riller et al.   JOURNAL OF NEUROLOGY

Interleukin-18 in Health and Disease

(2019) Koubun Yasuda et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Refractory sarcoidosis-like systemic granulomatosis responding to ruxolitinib

(2019) Michael Levraut et al.   ANNALS OF THE RHEUMATIC DISEASES

The cerebrospinal fluid CD 4/ CD 8 ratio and interleukin‐6 and ‐10 levels in neurosarcoidosis: a multicenter, pragmatic, comparative study

(2019) Thibaud Chazal et al.   EUROPEAN JOURNAL OF NEUROLOGY

Exome sequencing and pathogenicity-network analysis of 5 French families implicate mTOR signalling and autophagy in familial sarcoidosis

(2019) Alain Calender et al.   EUROPEAN RESPIRATORY JOURNAL

A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis

(2019) Katie Bechman et al.   RHEUMATOLOGY

Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases

(2019) Kübra Bunte et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Targeting mTOR for cancer therapy

(2019) Hui Hua et al.   Journal of Hematology & Oncology

Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulare

(2019) William Damsky et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Jak-inhibitors offer promise for a new era of targeted treatment for granulomatous disorders

(2019) M. Rosenbach   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Quantification of pulmonary disease activity in sarcoidosis measured with 18F-FDG PET/CT: SUVmax versus total lung glycolysis

(2019) Milou C. Schimmelpennink et al.   EJNMMI Research

Infliximab for Refractory Cardiac Sarcoidosis

(2019) Logan J. Harper et al.   AMERICAN JOURNAL OF CARDIOLOGY

Inflammasome Formation in Granulomas in Cardiac Sarcoidosis

(2019) Jordana Kron et al.   Circulation-Arrhythmia and Electrophysiology

Nonorgan manifestations of sarcoidosis

(2019) Jinny Tavee et al.   CURRENT OPINION IN PULMONARY MEDICINE

Advanced sarcoidosis

(2019) Robert P. Baughman et al.   CURRENT OPINION IN PULMONARY MEDICINE

Long‐Term Corticosteroid‐Sparing Immunosuppression for Cardiac Sarcoidosis

(2019) David G. Rosenthal et al.   Journal of the American Heart Association

Emerging insights into molecular mechanisms underlying pyroptosis and functions of inflammasomes in diseases

(2019) Fangfang Lu et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Emerging Activators and Regulators of Inflammasomes and Pyroptosis

(2019) Yansong Xue et al.   TRENDS IN IMMUNOLOGY

MAP kinase phosphatase-1, a gatekeeper of the acute innate immune response

(2019) Sean G. Kirk et al.   LIFE SCIENCES

Drug-Induced Sarcoidosis-Like Reactions

(2018) Amit Chopra et al.   CHEST

Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis

(2018) Claudia Fabiani et al.   CLINICAL RHEUMATOLOGY

Comparison of the efficacy and tolerability of tocilizumab, sarilumab, and sirukumab in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials

(2018) Sang-Cheol Bae et al.   CLINICAL RHEUMATOLOGY

Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies

(2018) Claudia Fabiani et al.   CLINICAL RHEUMATOLOGY

Molecular mechanisms of action of anti-TNF-α agents – Comparison among therapeutic TNF-α antagonists

(2018) Hiroki Mitoma et al.   CYTOKINE

Interleukin-1 blockade in cardiovascular diseases: a clinical update

(2018) Leo F Buckley et al.   EUROPEAN HEART JOURNAL

Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT

(2018) Sarah Brown et al.   HEALTH TECHNOLOGY ASSESSMENT

Muscular sarcoidosis under anti-TNF treatment in ankylosing spondylitis

(2018) Daniel Wendling et al.   JOINT BONE SPINE

Cutaneous sarcoidosis in a patient with rheumatoid arthritis receiving tocilizumab

(2018) Yuki Shono et al.   JOURNAL OF DERMATOLOGY

Translational and clinical advances in JAK-STAT biology: The present and future of jakinibs

(2018) Massimo Gadina et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Adalimumab in Active and Inactive, Non-Infectious Uveitis: Global Results from the VISUAL I and VISUAL II Trials

(2018) Hiroshi Goto et al.   OCULAR IMMUNOLOGY AND INFLAMMATION

Steroids for sarcoidosis: How much and for how long?

(2018) Robert P. Baughman et al.   RESPIRATORY MEDICINE

Efficacy and safety of infliximab biosimilar Inflectra ® in severe sarcoidosis

(2018) Milou C. Schimmelpennink et al.   RESPIRATORY MEDICINE

No evidence found for an association between prednisone dose and FVC change in newly-treated pulmonary sarcoidosis

(2018) Caroline E. Broos et al.   RESPIRATORY MEDICINE

Pulmonary sarcoidosis with and without extrapulmonary involvement: a cross-sectional and observational study in China

(2018) Cheng-Wei Li et al.   BMJ Open

Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients

(2018) Claudia Fabiani et al.   CLINICAL RHEUMATOLOGY

OUP accepted manuscript

(2018)   RHEUMATOLOGY

Reprint of: The pathology of pulmonary sarcoidosis: update

(2018) YanLing Ma et al.   SEMINARS IN DIAGNOSTIC PATHOLOGY

Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What’s the Difference?

(2018) Ali Berkant Avci et al.   BIODRUGS

Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia

(2018) Cécile Rotenberg et al.   EUROPEAN RESPIRATORY JOURNAL

Tofacitinib Treatment and Molecular Analysis of Cutaneous Sarcoidosis

(2018) William Damsky et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sarcoidosis: A benign disease or a culture of neglect?

(2018) Athol U. Wells   RESPIRATORY MEDICINE

Anti-tumor necrosis factor agents in sarcoidosis: A systematic review of efficacy and safety

(2018) Brandon L. Adler et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Autoimmune diseases induced by biological agents. A review of 12,731 cases (BIOGEAS Registry)

(2017) Marta Pérez-De-Lis et al.   Expert Opinion On Drug Safety

Sarcoidosis Following Anti-PD-1 and Anti-CTLA-4 Therapy for Metastatic Melanoma

(2017) Swathi B. Reddy et al.   JOURNAL OF IMMUNOTHERAPY

Long-term outcomes of refractory neurosarcoidosis treated with infliximab

(2017) Fleur Cohen Aubart et al.   JOURNAL OF NEUROLOGY

Repository corticotropin for Chronic Pulmonary Sarcoidosis

(2017) Robert P. Baughman et al.   LUNG

Infliximab for the treatment of CNS sarcoidosis

(2017) Jeffrey M. Gelfand et al.   NEUROLOGY

Propionibacterium acnes -associated neurosarcoidosis: A case report with review of the literature

(2017) Guang Yang et al.   NEUROPATHOLOGY

Clarifying Stem-Cell Therapy’s Benefits and Risks

(2017) Peter W. Marks et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

(2017) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sarcoidosis-associated small fiber neuropathy in a large cohort: Clinical aspects and response to IVIG and anti-TNF alpha treatment

(2017) Jinny O. Tavee et al.   RESPIRATORY MEDICINE

Toxicity risk from glucocorticoids in sarcoidosis patients

(2017) Nauman A. Khan et al.   RESPIRATORY MEDICINE

Aggravation d’une sarcoïdose après autogreffe de cellules souches hématopoïétiques : un effet paradoxal ?

(2017) A. Marchal et al.   REVUE DE MEDECINE INTERNE

Clinical characteristics of patients with bone sarcoidosis

(2017) Ying Zhou et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: A multicenter study of 132 patients

(2017) Yvan Jamilloux et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Quality of Life in Sarcoidosis

(2017) Marc Judson   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Comparative efficacy and tolerability of sarilumab 150 and 200 mg in patients with active rheumatoid arthritis

(2017) S.-C. Bae et al.   ZEITSCHRIFT FUR RHEUMATOLOGIE

Profile of sarilumab and its potential in the treatment of rheumatoid arthritis

(2017) Maria Gabriella Raimondo et al.   Drug Design Development and Therapy

Serious adverse events of cell therapy for respiratory diseases: a systematic review and meta-analysis

(2017) Runzhen Zhao et al.   Oncotarget

Efficacy and Tolerance of Anti–Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis

(2017) Valentine Heidelberger et al.   JAMA Dermatology

The Safety and Immunogenicity of Live Zoster Vaccination in Patients With Rheumatoid Arthritis Before Starting Tofacitinib: A Randomized Phase II Trial

(2017) Kevin L. Winthrop et al.   Arthritis & Rheumatology

Emerging and potential treatment options for sarcoidosis

(2017) Debabrata Bandyopadhyay et al.   Expert Opinion on Orphan Drugs

Identification of Jak-STAT signaling involvement in sarcoidosis severity via a novel microRNA-regulated peripheral blood mononuclear cell gene signature

(2017) Tong Zhou et al.   Scientific Reports

Outcome of tocilizumab treatment in refractory ocular inflammatory diseases

(2016) Sukhum Silpa-archa et al.   ACTA OPHTHALMOLOGICA

Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study

(2016) Dae Hyun Yoo et al.   ANNALS OF THE RHEUMATIC DISEASES

Sarcoidosis following successful treatment of pemphigus vulgaris with rituximab: a rituximab-induced reaction further supporting B-cell contribution to sarcoidosis pathogenesis?

(2016) F. Galimberti et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

FDG PET/CT Evidence of Effective Treatment of Cardiac Sarcoidosis With Adalimumab

(2016) Christina T. Miller et al.   CLINICAL NUCLEAR MEDICINE

Sarcoidosis: an update on current pharmacotherapy options and future directions

(2016) Pilar Brito-Zerón et al.   EXPERT OPINION ON PHARMACOTHERAPY

Biologic therapies in the treatment of sarcoidosis

(2016) Lesley Ann Saketkoo et al.   Expert Review of Clinical Immunology

Interleukin-1 Blockade in Acute Decompensated Heart Failure

(2016) Benjamin W. Van Tassell et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Treatment of neurosarcoidosis

(2016) Samuel Bitoun et al.   NEUROLOGY

Adalimumab in Patients with Active Noninfectious Uveitis

(2016) Glenn J. Jaffe et al.   NEW ENGLAND JOURNAL OF MEDICINE

Intravitreal Sirolimus for Noninfectious Uveitis: A Phase III Sirolimus Study Assessing Double-masKed Uveitis TReAtment (SAKURA)

(2016) Quan Dong Nguyen et al.   OPHTHALMOLOGY

Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab

(2016) Heleen A. Crommelin et al.   RESPIRATORY MEDICINE

A retrospective pilot study examining the use of Acthar gel in sarcoidosis patients

(2016) Robert P. Baughman et al.   RESPIRATORY MEDICINE

Corticosteroids in Sarcoidosis

(2016) Marc A. Judson   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Mesenchymal Stromal Cells Induce Peculiar Alternatively Activated Macrophages Capable of Dampening Both Innate and Adaptive Immune Responses

(2016) Laura Chiossone et al.   STEM CELLS

Infliximab Versus Adalimumab in the Treatment of Refractory Inflammatory Uveitis: A Multicenter Study From the French Uveitis Network

(2016) Hélène Vallet et al.   Arthritis & Rheumatology

Human Mesenchymal stem cells program macrophage plasticity by altering their metabolic status via a PGE2-dependent mechanism

(2016) Anoop Babu Vasandan et al.   Scientific Reports

Decreased Cytotoxic T-Lymphocyte Antigen 4 Expression on Regulatory T Cells and Th17 Cells in Sarcoidosis: Double Trouble?

(2015) Caroline E. Broos et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention

(2015) John J. O'Shea et al.   Annual Review of Medicine

IL-6 inhibitors for treatment of rheumatoid arthritis: past, present, and future

(2015) Go Woon Kim et al.   ARCHIVES OF PHARMACAL RESEARCH

Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis

(2015) Anne Bertrand et al.   BMC Medicine

Mycophenolate mofetil as a steroid-sparing agent in sarcoid-associated renal disease

(2015) Anita A. Zaidi et al.   CLINICAL NEPHROLOGY

Cellular Players in the Immunopathogenesis of Sarcoidosis

(2015) Gernot Zissel et al.   CLINICS IN CHEST MEDICINE

Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis

(2015) Adriane D.M. Vorselaars et al.   EUROPEAN RESPIRATORY JOURNAL

Longterm Safety of Rituximab: Final Report of the Rheumatoid Arthritis Global Clinical Trial Program over 11 Years

(2015) R. F. van Vollenhoven et al.   JOURNAL OF RHEUMATOLOGY

Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study

(2015) Marlies E. J. Reinders et al.   Journal of Translational Medicine

Inflammasomes: mechanism of action, role in disease and therapeutics

(2015) Haitao Guo et al.   NATURE MEDICINE

The effect of corticosteroids on quality of life in a sarcoidosis clinic: The results of a propensity analysis

(2015) Marc A. Judson et al.   RESPIRATORY MEDICINE

ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy

(2015) Adriane D.M. Vorselaars et al.   RESPIRATORY MEDICINE

Successful use of rituximab in refractory cardiac sarcoidosis

(2015) Megan L. Krause et al.   RHEUMATOLOGY

Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients

(2015) Leyre Riancho-Zarrabeitia et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

ACTH: The forgotten therapy

(2015) Trinidad Montero-Melendez   SEMINARS IN IMMUNOLOGY

Safety of mesenchymal stromal cell therapy for inflammatory bowel diseases: Results of a 5-year follow-up

(2015) O. V. Knyazev et al.   TERAPEVTICHESKII ARKHIV

Systematic review and meta-analysis of serious infections with tofacitinib and biologic disease-modifying antirheumatic drug treatment in rheumatoid arthritis clinical trials

(2015) Vibeke Strand et al.   ARTHRITIS RESEARCH & THERAPY

New treatment strategies for pulmonary sarcoidosis: antimetabolites, biological drugs, and other treatment approaches

(2015) Robert P Baughman et al.   Lancet Respiratory Medicine

One-Year Outcomes of the SAVE Study:Sirolimus as a TherapeuticApproach for UVEitis

(2015) Mohamed A. Ibrahim et al.   Translational Vision Science & Technology

Systemic sarcoidosis induced by etanercept: first Brazilian case report

(2014) Natasha Unterstell et al.   ANAIS BRASILEIROS DE DERMATOLOGIA

Mononeuritis multiplex as the first presentation of refractory sarcoidosis responsive to etanercept

(2014) Inês Brás Marques et al.   BMC Neurology

Mechanisms and Functions of Inflammasomes

(2014) Mohamed Lamkanfi et al.   CELL

Rapamycin: One Drug, Many Effects

(2014) Jing Li et al.   Cell Metabolism

Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity

(2014) P.H. Schafer et al.   CELLULAR SIGNALLING

A Randomized, Investigator-Masked, Double-Blind, Placebo-Controlled Trial on Thalidomide in Severe Cutaneous Sarcoidosis

(2014) Catherine Droitcourt et al.   CHEST

Cytotoxic agents in sarcoidosis

(2014) Adriane D.M. Vorselaars et al.   CURRENT OPINION IN PULMONARY MEDICINE

IL-12-and IL-23 in health and disease

(2014) Andrew L. Croxford et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Apremilast: First Global Approval

(2014) Raewyn M. Poole et al.   DRUGS

Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis

(2014) M. A. Judson et al.   EUROPEAN RESPIRATORY JOURNAL

Rituximab in the treatment of refractory pulmonary sarcoidosis

(2014) N. J. Sweiss et al.   EUROPEAN RESPIRATORY JOURNAL

Association of the TNF-  G-308A polymorphism with TNF-inhibitor response in sarcoidosis

(2014) P. A. Wijnen et al.   EUROPEAN RESPIRATORY JOURNAL

Tocilizumab for treating rheumatoid arthritis: an evaluation of pharmacokinetics/pharmacodynamics and clinical efficacy

(2014) Soken-Nakazawa J Song et al.   Expert Opinion on Drug Metabolism & Toxicology

Early-onset Crohn’s disease and autoimmunity associated with a variant in CTLA-4

(2014) Sebastian Zeissig et al.   GUT

Anti-TNF therapeutics for the treatment of sarcoidosis

(2014) Heleen A Crommelin et al.   Immunotherapy

T Cell Responses to Mycobacterial Catalase-Peroxidase Profile a Pathogenic Antigen in Systemic Sarcoidosis

(2014) E. S. Chen et al.   JOURNAL OF IMMUNOLOGY

Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations

(2014) Desirée Schubert et al.   NATURE MEDICINE

mTOR pathway: A current, up-to-date mini-review (Review)

(2014) PAUL ZAROGOULIDIS et al.   Oncology Letters

Efficacy of Adalimumab in Chronically Active and Symptomatic Patients with Sarcoidosis

(2013) Lieke S. Kamphuis et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012: Table 1

(2013) Daniel E Furst et al.   ANNALS OF THE RHEUMATIC DISEASES

A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study

(2013) Dae Hyun Yoo et al.   ANNALS OF THE RHEUMATIC DISEASES

Etanercept may induce neurosarcoidosis in a patient treated for rheumatoid arthritis

(2013) Cécile-Audrey Durel et al.   BMC Neurology

A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea

(2013) Srdan Verstovsek et al.   CANCER

Methotrexate vs Azathioprine in Second-line Therapy of Sarcoidosis

(2013) Adriane D.M. Vorselaars et al.   CHEST

Nicotine Treatment Improves Toll-Like Receptor 2 and Toll-Like Receptor 9 Responsiveness in Active Pulmonary Sarcoidosis

(2013) Mark W. Julian et al.   CHEST

Mechanisms of Immune Modulation by Mesenchymal Stromal Cells and Clinical Translation

(2013) J. Stagg et al.   CURRENT MOLECULAR MEDICINE

Multinational evidence-based World Association of Sarcoidosis and Other Granulomatous Disorders recommendations for the use of methotrexate in sarcoidosis

(2013) Johanna P. Cremers et al.   CURRENT OPINION IN PULMONARY MEDICINE

Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis

(2013) A. D. M. Vorselaars et al.   EUROPEAN RESPIRATORY JOURNAL

Established and experimental medical therapy of pulmonary sarcoidosis

(2013) Robert P. Baughman et al.   EUROPEAN RESPIRATORY JOURNAL

Sarcoidosis in donor-derived tissues after haematopoietic stem cell transplantation: Table 1–

(2013) Hisako Kushima et al.   EUROPEAN RESPIRATORY JOURNAL

The IL-2/IL-2R system: from basic science to therapeutic applications to enhance immune regulation

(2013) Allison L. Bayer et al.   IMMUNOLOGIC RESEARCH

Sarcoidosis associated with neuromyelitis optica

(2013) Raja Sawaya et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Reversal of Global CD4+ Subset Dysfunction Is Associated with Spontaneous Clinical Resolution of Pulmonary Sarcoidosis

(2013) K. A. Oswald-Richter et al.   JOURNAL OF IMMUNOLOGY

Sarcoidosis Induced by Tocilizumab: A Paradoxical Event?

(2013) A. NUTZ et al.   JOURNAL OF RHEUMATOLOGY

Antinuclear antibodies do not predict anti-infliximab antibody induction in sarcoidosis

(2013) Adriane Dore Marie Vorselaars et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Sarcoidosis

(2013) Dominique Valeyre et al.   LANCET

JAKs and STATs in Immunity, Immunodeficiency, and Cancer

(2013) John J. O'Shea et al.   NEW ENGLAND JOURNAL OF MEDICINE

Successful Treatment of Ocular Sarcoidosis with Rituximab

(2013) Enrico Beccastrini et al.   OCULAR IMMUNOLOGY AND INFLAMMATION

The potential additional benefit of infliximab in patients with chronic pulmonary sarcoidosis already receiving corticosteroids: A retrospective analysis from a randomized clinical trial

(2013) Marc A. Judson et al.   RESPIRATORY MEDICINE

Hypercalcémie majeure révélatrice d’une sarcoïdose induite par étanercept

(2013) A. Watrin et al.   REVUE DES MALADIES RESPIRATOIRES

Sarcoid-like granulomatosis in a patient treated by interleukin-1 receptor antagonist for TNF-receptor-associated periodic syndrome

(2013) K. Sacre et al.   RHEUMATOLOGY

Elevated serum BAFF levels in patients with sarcoidosis: association with disease activity

(2013) Ikuko Ueda-Hayakawa et al.   RHEUMATOLOGY

Long term follow-up of infliximab efficacy in pulmonary and extra-pulmonary sarcoidosis refractory to conventional therapy

(2013) Eric Russell et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Oral Antimycobacterial Therapy in Chronic Cutaneous Sarcoidosis

(2013) Wonder P. Drake et al.   JAMA Dermatology

Granuloma Formation in Pulmonary Sarcoidosis

(2013) Caroline E. Broos et al.   Frontiers in Immunology

Multiple Sclerosis, Relapses, and the Mechanism of Action of Adrenocorticotropic Hormone

(2013) Amy Perrin Ross et al.   Frontiers in Neurology

A case of sarcoidosis in a patient with testicular cancer post stem cell transplant

(2012) Minyuen Teo et al.   ACTA ONCOLOGICA

Safety and efficacy of mesenchymal stromal cell therapy in autoimmune disorders

(2012) Maria Ester Bernardo et al.   Annals of the New York Academy of Sciences

Inflammasomes and Their Roles in Health and Disease

(2012) Mohamed Lamkanfi et al.   Annual Review of Cell and Developmental Biology

Thalidomide for improving cutaneous and pulmonary sarcoidosis in patients resistant or with contraindications to corticosteroids

(2012) P. Fazzi et al.   BIOMEDICINE & PHARMACOTHERAPY

mTOR Signaling in Growth Control and Disease

(2012) Mathieu Laplante et al.   CELL

Sarcoidosis: An underestimated and potentially severe side effect of anti-TNF-alpha therapy

(2012) Camille Vigne et al.   JOINT BONE SPINE

Dual Analysis for Mycobacteria and Propionibacteria in Sarcoidosis BAL

(2012) Kyra A. Oswald-Richter et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Sarcoidosis Th17 Cells are ESAT-6 Antigen Specific but Demonstrate Reduced IFN-γ Expression

(2012) Bradley W. Richmond et al.   JOURNAL OF CLINICAL IMMUNOLOGY

A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis

(2012) Robert J. Pariser et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Active Chronic Sarcoidosis is Characterized by Increased Transitional Blood B Cells, Increased IL-10-Producing Regulatory B Cells and High BAFF Levels

(2012) Anne Saussine et al.   PLoS One

Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials

(2012) Manoj M. Lalu et al.   PLoS One

Effect and Safety of Mycophenolate Mofetil in Chronic Pulmonary Sarcoidosis: A Retrospective Study

(2012) Anne-Kathrin Brill et al.   RESPIRATION

Efficacy and Safety of TNF Antagonists in Sarcoidosis: Data from the Spanish Registry of Biologics BIOBADASER and a Systematic Review

(2012) Jose Ramon Maneiro et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Kinase inhibitors: a new class of antirheumatic drugs

(2012) Vasileios Kyttaris   Drug Design Development and Therapy

Pulmonary Disorders Induced by Monoclonal Antibodies in Patients with Rheumatologic Autoimmune Diseases

(2011) Manuel Ramos-Casals et al.   AMERICAN JOURNAL OF MEDICINE

M2 Polarized Macrophages and Giant Cells Contribute to Myofibrosis in Neuromuscular Sarcoidosis

(2011) Stefan Prokop et al.   AMERICAN JOURNAL OF PATHOLOGY

Sarcoidosis-related Mortality in the United States from 1988 to 2007

(2011) Jeffrey J. Swigris et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Novel Murine Model of Chronic Granulomatous Lung Inflammation Elicited by Carbon Nanotubes

(2011) Isham Huizar et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Efficacy and Safety of Apremilast in Chronic Cutaneous Sarcoidosis

(2011) Robert P. Baughman   ARCHIVES OF DERMATOLOGY

Disturbed Homeostasis and Multiple Signaling Defects in the Peripheral Blood B-Cell Compartment of Patients with Severe Chronic Sarcoidosis

(2011) Nam-Sihk Lee et al.   Clinical and Vaccine Immunology

Regulatory T cells with reduced repressor capacities are extensively amplified in pulmonary sarcoid lesions and sustain granuloma formation

(2011) Gunter Rappl et al.   CLINICAL IMMUNOLOGY

Effect of the TNF-α inhibitor adalimumab in patients with recalcitrant sarcoidosis: a prospective observational study using FDG-PET

(2011) Nils Milman et al.   Clinical Respiratory Journal

Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis

(2011) D. H. Sahoo et al.   EUROPEAN RESPIRATORY JOURNAL

Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis

(2011) R. J. Erckens et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognised complication

(2011) D. Tong et al.   INTERNAL MEDICINE JOURNAL

Sarcoidosis

(2011) Michael C. Iannuzzi   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A 24-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy of Oral SCIO-469, a p38 Mitogen-activated Protein Kinase Inhibitor, in Patients with Active Rheumatoid Arthritis

(2011) MARK C. GENOVESE et al.   JOURNAL OF RHEUMATOLOGY

Rapamycin passes the torch: a new generation of mTOR inhibitors

(2011) Don Benjamin et al.   NATURE REVIEWS DRUG DISCOVERY

Sarcoidosis—scientific progress and clinical challenges

(2011) Edward S. Chen et al.   Nature Reviews Rheumatology

Mycophenolate mofetil may be effective in CNS sarcoidosis but not in sarcoid myopathy

(2011) G. Androdias et al.   NEUROLOGY

Long-Term Treatment with Infliximab in Patients with Sarcoidosis

(2011) Katrin E. Hostettler et al.   RESPIRATION

Increased IL-17A expression in granulomas and in circulating memory T cells in sarcoidosis

(2011) Bregje ten Berge et al.   RHEUMATOLOGY

Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4

(2011) O. S. Qureshi et al.   SCIENCE

Successful treatment of systemic de novo sarcoidosis with cyclosporine discontinuation and provision of rapamune after liver transplantation

(2011) Tommaso Maria Manzia et al.   TRANSPLANT INTERNATIONAL

Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: Results from the Autoimmunity and Rituximab Registry

(2011) X. Puéchal et al.   ARTHRITIS CARE & RESEARCH

Inhaled Vasoactive Intestinal Peptide Exerts Immunoregulatory Effects in Sarcoidosis

(2010) Antje Prasse et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Dysregulation of p38 and MKP-1 in Response to NOD1/TLR4 Stimulation in Sarcoid Bronchoalveolar Cells

(2010) Ruchi Rastogi et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: Results of a multicenter, phase II, dose-ranging study

(2010) Alexander So et al.   ARTHRITIS AND RHEUMATISM

The CD4 + Lymphopenic Sarcoidosis Phenotype Is Highly Responsive to Anti-Tumor Necrosis Factor-α Therapy

(2010) Elliott D. Crouser et al.   CHEST

Tumor necrosis factor-alpha (TNF-α)-blockade-induced hepatic sarcoidosis in psoriatic arthritis (PsA): case report and review of the literature

(2010) Raquel Cuchacovich et al.   CLINICAL RHEUMATOLOGY

Association of inflammatory bowel disease risk loci with sarcoidosis, and its acute and chronic subphenotypes

(2010) A. Fischer et al.   EUROPEAN RESPIRATORY JOURNAL

Canakinumab for treatment of cryopyrin-associated periodic syndrome

(2010) Eugen Feist et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease

(2010) I. Dotan et al.   GUT

Comparative analysis of the effects of anti-IL-6 receptor mAb and anti-TNF mAb treatment on CD4+ T-cell responses in murine colitis

(2010) Fumitaka Terabe et al.   INFLAMMATORY BOWEL DISEASES

Tumor Necrosis Factor-Alpha Antagonist-Induced Sarcoidosis

(2010) Rochelle Robicheaux Clementine et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Stimulation of  7 Nicotinic Acetylcholine Receptor by Nicotine Increases Suppressive Capacity of Naturally Occurring CD4+CD25+ Regulatory T Cells in Mice In Vitro

(2010) D.-w. Wang et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

A CASE OF NEUROSARCOIDOSIS SUCCESSFULLY TREATED WITH RITUXIMAB

(2010) R. Bomprezzi et al.   NEUROLOGY

The Expression of STAT-1 and Phosphorylated STAT-1 in Conjunctival Granulomas

(2010) James T. Rosenbaum et al.   OCULAR IMMUNOLOGY AND INFLAMMATION

Everyday Cognitive Failure in Sarcoidosis: The Prevalence and the Effect of Anti-TNF-α Treatment

(2010) Marjon D. Elfferich et al.   RESPIRATION

Pharmacotherapy for pulmonary sarcoidosis: A delphi consensus study

(2010) Amanda C. Schutt et al.   RESPIRATORY MEDICINE

Infliximab et sarcoïdose chronique. L’expérience française à propos de 31 cas

(2010) F. Jounieaux et al.   REVUE DES MALADIES RESPIRATOIRES

Nicotine inhibits tumor necrosis factor-α induced IL-6 and IL-8 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis

(2010) Yaou Zhou et al.   RHEUMATOLOGY INTERNATIONAL

The Etiologic Role of Infectious Antigens in Sarcoidosis Pathogenesis

(2010) Kyra Oswald-Richter et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Osseous Sarcoidosis Treated With Tumor Necrosis Factor-Inhibitors

(2010) Sarfaraz A. Hasni et al.   SPINE

Sarcoidosis is a Th1/Th17 multisystem disorder

(2010) M. Facco et al.   THORAX

The role of tumor necrosis factor alpha G-308A polymorphisms in the course of pulmonary sarcoidosis

(2010) P. A. Wijnen et al.   TISSUE ANTIGENS

Apremilast: a novel PDE4 inhibitor in the treatment of autoimmune and inflammatory diseases

(2010) Georg Schett et al.   Therapeutic Advances in Musculoskeletal Disease

FoxP3+ Regulatory T Cells Suppress Early Stages of Granuloma Formation but Have Little Impact on Sarcoidosis Lesions

(2009) Cécile Taflin et al.   AMERICAN JOURNAL OF PATHOLOGY

Serum Amyloid A Regulates Granulomatous Inflammation in Sarcoidosis through Toll-like Receptor-2

(2009) Edward S. Chen et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Efficacy of Short-Course, Low-Dose Corticosteroid Therapy for Acute Pulmonary Sarcoidosis Exacerbations

(2009) Brian P. McKinzie et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Efficacy and safety of pamapimod in patients with active rheumatoid arthritis receiving stable methotrexate therapy

(2009) R E Alten et al.   ANNALS OF THE RHEUMATIC DISEASES

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009

(2009) D E Furst et al.   ANNALS OF THE RHEUMATIC DISEASES

Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis

(2009) Stanley B. Cohen et al.   ARTHRITIS AND RHEUMATISM

Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: Results of two randomized, double-blind, placebo-controlled clinical studies

(2009) Nemanja Damjanov et al.   ARTHRITIS AND RHEUMATISM

Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis

(2009) PH Schafer et al.   BRITISH JOURNAL OF PHARMACOLOGY

Changes in Chest Roentgenogram of Sarcoidosis Patients During a Clinical Trial of Infliximab Therapy

(2009) Robert P. Baughman et al.   CHEST

Hypothesis: Sarcoidosis is a STAT1-mediated disease

(2009) James T. Rosenbaum et al.   CLINICAL IMMUNOLOGY

Prevalence of sarcoidosis in Switzerland is associated with environmental factors

(2009) U. Deubelbeiss et al.   EUROPEAN RESPIRATORY JOURNAL

Cellular Responses to Mycobacterial Antigens Are Present in Bronchoalveolar Lavage Fluid Used in the Diagnosis of Sarcoidosis

(2009) K. A. Oswald-Richter et al.   INFECTION AND IMMUNITY

Uveitis associated with sarcoidosis exacerbated by etanercept therapy

(2009) Jun Suzuki et al.   JAPANESE JOURNAL OF OPHTHALMOLOGY

Relapse of severe sarcoidosis with an uncommon peritoneal location after TNFα blockade. Efficacy of rituximab, report of a single case

(2009) Virginie Dasilva et al.   JOINT BONE SPINE

Mycobacterial ESAT-6 and katG are Recognized by Sarcoidosis CD4+ T Cells When Presented by the American Sarcoidosis Susceptibility Allele, DRB1*1101

(2009) Kyra Oswald-Richter et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Activation of the Cholinergic Anti-Inflammatory System by Nicotine Attenuates Neuroinflammation via Suppression of Th1 and Th17 Responses

(2009) E. Nizri et al.   JOURNAL OF IMMUNOLOGY

Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil

(2009) M. Moravan et al.   NEUROLOGY

Clinical outcomes in sarcoidosis after cessation of infliximab treatment

(2009) Efstratios PANSELINAS et al.   RESPIROLOGY

Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases

(2009) C. I. Daien et al.   RHEUMATOLOGY

Dose-related patterns of glucocorticoid-induced side effects

(2008) D Huscher et al.   ANNALS OF THE RHEUMATIC DISEASES

Autoimmune diseases induced by TNF-targeted therapies

(2008) Manuel Ramos-Casals et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Convergence of alpha 7 nicotinic acetylcholine receptor-activated pathways for anti-apoptosis and anti-inflammation: Central role for JAK2 activation of STAT3 and NF-κB

(2008) Mario B. Marrero et al.   BRAIN RESEARCH

The Treatment of Lupus Pernio

(2008) Eleni Stagaki et al.   CHEST

The effects of IL-6 on CD4 T cell responses

(2008) Oliver Dienz et al.   CLINICAL IMMUNOLOGY

Etiology of Sarcoidosis

(2008) Edward S. Chen et al.   CLINICS IN CHEST MEDICINE

The Immunology of Sarcoidosis

(2008) Alicia K. Gerke et al.   CLINICS IN CHEST MEDICINE

Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial

(2008) M. A. Judson et al.   EUROPEAN RESPIRATORY JOURNAL

Rituximab as a treatment alternative in sarcoidosis

(2008) Ahlam Belkhou et al.   JOINT BONE SPINE

Treatment of refractory neurosarcoidosis with Infliximab

(2008) E. Santos et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Unknown

(2008) William Parrish et al.   MOLECULAR MEDICINE

Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production

(2008) Krisztián Németh et al.   NATURE MEDICINE

Infliximab therapy rescues cyclophosphamide failure in severe central nervous system sarcoidosis

(2008) Manica Sodhi et al.   RESPIRATORY MEDICINE

Abatacept in the treatment of rheumatoid arthritis

(2008) Maya H Buch et al.   ARTHRITIS RESEARCH & THERAPY